Jimmy CHENG-HO LIN
Rare Genomics Institute (USA)
Dr. Jimmy Cheng-Ho Lin leads Rare Genomics Institute, a non-profit biotech venture that
microfunds and enables genome sequencing for children with rare and orphan diseases.
He is also a faculty member in the department of Pathology in Washington University in St.
Prior to RGI, he was the the lead computational biologist for the ground-breaking cancer
genome sequencing efforts from the Vogelstein Lab at Johns Hopkins.
Their sequencing of
the first 100+ cancer exomes in 5 different tissue types has helped lay the foundation for a
revolution in cancer genomics.
Jimmy is an expert in next-generation sequencing, cancer
genomics, and bioinformatics. He holds a BA/BS from
Yale University, MHS in Bioinformatics from Johns Hopkins School of Public Health, and
PhD from Johns Hopkins School of Medicine.
His passion is to bring sequencing
technologies for those in need using a sustainable social entrepreneurship model. For these
efforts, he was awarded the TED fellowship in 2012.
Crowdsourcing research and funds for rare diseases
- Rare diseases as long tail problem
- Opportunity with high-throughput biology
- Initial experiences with Rare Genomics Institute
- Challenges and future directions with crowdsource funding and research